Director Health Economics and Outcomes Research
BD Urology and Critical Care, US
Timothy Kelly, MS, MBA is Director of Health Economics and Outcomes Research at BD Urology and Critical Care. Prior to that, he served as Director of Marketing at Taylor Healthcare. Tim holds master’s degrees in biomedical engineering from Drexel University and in business administration from Mercer University. Tim has spent 25 years in the medical device and medical software industries at various firms including C.R. Bard, Inc., Dialog Medical, and Taylor Healthcare. He also spent two years as a Fellow with the Biomedical Engineering and Science Institute of Drexel University. Tim’s areas of interest include infection prevention, critical care medicine, endourology, risk management, and patient safety.
An avid researcher, Tim designs both randomized controlled trials and real-world data analyses that are constructed to evaluate the clinical and economic effects of various diseases and conditions. His 2024 and 2023 publications include papers in the journals Infection Control & Hospital Epidemiology, Urology and Therapeutic Hypothermia and Temperature Management. His real-world data analyses have examined hospital-onset infections have included studies of CAUTIs, non-CAUTI hospital-onset UTIs, HOB, and Clostridioides difficile.
Tim is a member of APIC, ISPOR, HIMSS, and MAPS. He has presented both podium sessions and posters at diverse national conferences, including IDWeek, APIC, HIMSS, ISPOR, AUA, ASHRM, IHI, and ACRP. He holds two U.S. patents and one international patent.
